🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT06696469
Recruiting Observational

Feasibility and Reliability of Using BeCureTM Virtual Reality in Patients With Stroke

NCT06696469 · tracked via the Priya Life Science Turkey tracker
Phase
Observational
Started
2024-06-22
Last updated
2024-11-22

Condition(s) studied

Stroke Patients

Investigational drug(s) / intervention(s)

Feasibility and reliability of using BeCureTM Virtual Reality in the evaluation of upper extremity motor functions in stroke patients

Feasibility and reliability of using BeCureTM Virtual Reality in the evaluation of upper extremity motor functions in stroke patients: The applicability and reliability of virtual reality systems are important factors to consider. Based on this, this study aimed to investigate the feasibility of using BeCureTM virtual reality in the evaluation of upper extremity functions after stroke.The feasibility of using BeCureTM virtual reality in stroke patients will be determined according to the System Usability Scale (SUS) score.The safety of the use of BeCureTM virtual reality in stroke patients will be assessed with a patient feedback questionnaire. The relationship between the use of BeCureTM virtual reality and cognitive functions in stroke patients will be determined by the Montreal Cognitive Assessment Scale and Mini Mental State Examination.It was aimed to examine the effects of demographic characteristics, accompanying cognitive disorders and upper extremity motor disorders that may affect the evaluation and response to treatment on virtual reality applications.

Study summary

The aim of this study is to demonstrate the feasibility and reliability of using virtual reality-based BeCureTM in the assessment of upper extremity motor functions in stroke patients.It is necessary to define the appropriate patient profile for the evaluation of upper extremity motor functions in stroke patients with virtual reality method. We aimed to examine the effects of demographic characteristics, accompanying cognitive disorders and upper extremity motor disorders that may affect the evaluation and response to treatment on virtual reality applications. Therefore, BeCure TM virtual reality system can be feasibly used in the evaluation and rehabilitation of stroke patients.

Eligibility

Sex
ALL
Min age
18 Years
Max age
80 Years
Healthy volunteers
Accepted
Inclusion Criteria: 1. Patients diagnosed with stroke according to the World Health Organization with an age range of 18-80 years 2. Patients with subacute to chronic stroke 3. Patients who can understand commands 4. Patients with sitting balance 5. Patients with a first stroke attack 6. Patients who have never received virtual reality therapy 7. Upper extremity Brunnstrom Stage III and above 8. Patients with a spasticity level below 3 according to the Modified Ashworth Scale (MAS) in the affected upper extremity (MAS 1-5 rating system) 9. Patients who agreed to participate in the study and signed the informed consent form Exclusion Criteria: 1. History of seizures or epilepsy (except childhood febrile seizures), 2. Arthritis or pain in the affected upper limb that limits repetitive exercise, 3. Severe aphasia, cognitive impairment (premorbid dementia) or psychiatric disorders, 4. Spasticity in the affected arm is 3 or more compared to MAS, 5. Patients without sitting balance, 6. Patients with posterior cerebral artery infarction, 7. Patients with subarachnoid hemorrhage, 8. Patients with visual impairments that may affect the virtual reality application

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Ankara University School of Medicine Department of Physical Medicine and Rehabilitation Ankara Turkey (Türkiye) Recruiting

More Ankara University trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06696469 on ClinicalTrials.gov ↗ ← All trials in Turkey